Confidential mandate

Aerospace Inbound-Resilience Board Adviser

Planned Hiring / New

Aerospace Inbound-Resilience Board Adviser mandate in Toulouse, France · Aerospace Manufacturing Logistics

An aircraft manufacturer needs independent board challenge on owned inbound resilience where specialised parts, export controls and supplier recovery options converge on fixed assembly positions.

The mandate

Final assembly plans depend on structures, engines, cabin monuments and controlled electronics whose transport alternatives are constrained by geometry, equipment, permits, export licences or qualified handling. Supplier continuity reports identify second sources, yet the board cannot see whether tooling, certification, route and line-integration time make an alternative executable. The adviser’s standing question is which inbound dependency can stop a fixed assembly position, how long recovery truly takes, and what option preserves programme value before disruption.

The cadence is four days monthly: one dependency-and-programme review, one recovery-evidence challenge, chair preparation and either committee attendance or supplier-to-line observation. Six committee sessions and five field visits are included. A material part or corridor question receives a response within forty-eight hours. Live production, supplier direction, export decisions, quality release, transport booking and programme commitments remain with authorised executives.

The term lasts eleven months through rate-readiness review, two programme gates and a disruption exercise. If the second gate slips, the chair may extend the appointment for a final month after a fresh independence review. The adviser then closes with dependency archetypes, time-to-recovery evidence, option conditions, decision history and board gates for buffer, tooling, alternate route, supplier intervention, rate commitment and controlled programme resequence.

The adviser has no line authority, executive responsibility, procurement agency, production role, export licence authority or board vote. Operations runs final assembly; Quality and engineering approve parts; trade teams determine controls; directors choose investment. The adviser may challenge dependency maps, buffers, recovery time and alternative claims, but cannot release parts, direct suppliers, book special transport, determine export status, change build sequence or commit customers.

Relationships with aerospace suppliers, special-freight providers, tooling firms, aircraft lessors, airlines, engineering organisations, insurers, governments or investors require disclosure. A current role involving a supplier or programme under review triggers recusal. Other non-conflicting work may continue within cadence. Compensation is independent of aircraft delivery, rate approval, supplier award, inventory investment, freight choice, programme milestone or recovery outcome.

Why the board wants this voice

Programme, procurement and logistics leaders each know their component of resilience, but optimistic alternatives persist until a part must physically reach a certified position. Directors want an aerospace operator who has managed supplier-to-line recovery and can expose shared equipment, permit and qualification constraints. Independent challenge should improve capital choices without directing the live programme.

What you will own

  • Press management to trace priority parts from supplier release through special handling, export, route, customs, hub, plant and line acceptance.
  • Segment dependencies by assembly consequence, geometry, certification, tooling, transport equipment, jurisdiction, shelf life and recovery lead time.
  • Challenge alternate-source and route claims that omit industrialisation, qualified handlers, fixtures, permits or line-integration windows.
  • Examine buffers and recovery options for working capital, preservation, obsolescence, programme resequence and shared-equipment exposure.
  • Shape board gates for buffer investment, alternate qualification, supplier intervention, route proof, rate release and programme escalation.
  • Maintain an independent record of conflicts, expired assumptions, hidden common dependencies, conditions and adviser dissent.
  • Leave the committee a supplier-to-line resilience review tied to fixed assembly positions and executable recovery evidence.

Candidate qualifications

  • Has governed aerospace inbound, final-assembly supply or equivalent certification-constrained manufacturing logistics at executive level.
  • Can evidence a resilience investment changed after an alternate source or route proved non-executable in the required window.
  • Understands major structures, special transport, tooling, export control, customs, quality release, line positions and programme economics.
  • Has challenged programme and procurement leaders without directing suppliers or making engineering and trade determinations.
  • Can distinguish contracted alternate, industrially qualified source, transport-ready part and accepted line-side capability.
  • Is independent of material suppliers, freight providers, tooling firms, airline customers, insurers and programme investors.

Non-negotiables

  • Can attend six Toulouse committee sessions and complete five supplier-to-line evidence visits internationally.
  • Will not direct suppliers, release parts, determine export status, book transport or change production sequence.
  • Brings direct aerospace supplier-to-line resilience; generic business-continuity or freight procurement alone is insufficient.
  • Will disclose supplier, freight, tooling, airline, government and investor relationships before programme review.
  1. 49 words maximum. Which aerospace alternate looked credible until tooling, transport or line acceptance was tested?
  2. 49 words maximum. What supplier, freight, tooling, airline or investor interests require disclosure here?
  3. 49 words maximum. When did a fixed assembly position change your preferred resilience investment?

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.